Market Overview

According to MarketGenics, the global Point-of-Care Diagnostics Market was valued at USD 16.3 billion in 2025 and is projected to reach USD 35.3 billion by 2035, expanding at a CAGR of 8.0% during the forecast period. Glucose monitoring products represent the largest product segment, accounting for approximately 39% of the market in 2025. The market is expanding as healthcare providers increasingly adopt portable and decentralized diagnostic solutions that deliver rapid results at or near the patient's location.

To obtain a free sample research report - https://marketgenics.co/download-report-sample/point-of-care-diagnostics-market-55133

Market Growth Drivers

Key growth drivers include the increasing prevalence of diabetes, cardiovascular diseases, infectious diseases, and other chronic conditions, creating greater demand for rapid and continuous testing. Growing adoption of home-based healthcare, telemedicine, decentralized diagnostics, AI-powered testing, connected devices, cloud analytics, and wearable technologies is further accelerating market development. Rapid results enable faster clinical decision-making, while mobile connectivity and AI analytics support remote patient monitoring and integration with electronic health records.

Key Players

The competitive landscape is moderately consolidated, with the top five players accounting for approximately 40% of the market in 2025. Key players identified by MarketGenics include Abbott Laboratories, Becton, Dickinson and Company, bioMérieux, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, QIAGEN, Siemens Healthineers, Thermo Fisher Scientific, QuidelOrtho, Sysmex, Nova Biomedical, OraSure Technologies, and Werfen. Competition is focused on rapid testing technologies, portable analyzers, glucose monitoring, infectious-disease testing, connected diagnostics, and AI-enabled point-of-care solutions.

Regional Insights

North America dominates the Point-of-Care Diagnostics Market and is identified by MarketGenics as the most attractive region, supported by advanced healthcare infrastructure, high healthcare spending, established reimbursement systems, strong adoption of rapid testing, and technological innovation. Asia Pacific is expected to record the fastest growth, driven by healthcare digitization, increasing awareness of preventive care, underserved populations, affordable portable diagnostics, and government healthcare initiatives. Europe and other emerging markets are also expanding as decentralized healthcare and rapid diagnostic solutions gain adoption.

Related Reports:

AI Agents Market

Penetration Testing as Service Market

AI-powered Analytics Market

Soil Conditioners Market

Peptide Stabilization Market

Contact:
Mr. Debashish Roy
MarketGenics Global Research
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co